Theranostics 2017, Vol. 7, Issue 15
3651
7. Kolishetti N, Dhar S, Valencia PM, et al. Engineering of self-assembled
nanoparticle platform for precisely controlled combination drug therapy. Proc
Natl Acad Sci U S A. 2010; 107: 17939-44.
8. Ma L, Kohli M, Smith A. Nanoparticles for combination drug therapy. ACS
Nano. 2013; 7: 9518-25.
Abbreviations
DL, drug loading; EPR, enhanced permeability
and retention; PTX, paclitaxel; DTX, docetaxel; CTX,
9. Woodcock J, Griffin JP, Behrman RE. Development of novel combination
cabazitaxel;
7-ethyl-10-hydroxycamptothecin;
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[
methoxy (polyethylene glycol) 2000]; NIR,
NPs,
nanoparticles;
SN38,
therapies. N Engl J Med. 2011; 364: 985-7.
10. Humphrey RW, Brockway-Lunardi LM, Bonk DT, et al. Opportunities and
challenges in the development of experimental drug combinations for cancer. J
Natl Cancer Inst. 2011; 103: 1222-6.
11. Sun R, Liu Y, Li SY, et al. Co-delivery of all-trans-retinoic acid and doxorubicin
for cancer therapy with synergistic inhibition of cancer stem cells.
Biomaterials. 2015; 37: 405-14.
12. Yang T, Zhao PX, Rong Z, et al. Anti-tumor efficiency of lipid-coated cisplatin
nanoparticles co-loaded with microRNA-375. Theranostics. 2016; 6: 142-54.
13. Zhang XD, Yang Y, Liang X, et al. Enhancing therapeutic effects of
docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with
autophagy inhibitor on breast cancer. Theranostics. 2014; 4: 1085-95.
14. Hu XL, Hu JM, Tian J, et al. Polyprodrug amphiphiles: hierarchical assemblies
for shape-regulated cellular internalization, trafficking, and drug delivery. J
Am Chem Soc. 2013; 135: 17617-29.
DSPE-PEG2000
,
near-infrared fluorescence; Cy5.5, Cyanine5.5; DI,
Deionized; DMAP, 4-dimethylaminopyridine; DCM,
dichloromethane; DMF, dimethylformamide; NMR,
nuclear magnetic resonance; RT-HPLC, reverse-phase
high-performance liquid chromatography; FBS, fetal
bovine serum; PBS, phosphate buffer saline; DMSO,
dimethyl sulfoxide; TEM, transmission electron
microscopy; DLS, dynamic light scattering; DH,
hydrodynamic diameters; PDIs, low polydispersity
indices; EE, encapsulation efficiency; RES, the
reticuloendothelial system; CI, combination index;
c-PARP, cleaved poly (ADP-ribose) polymerase;
15. Hu XL, Liu GH, Li Y, et al. Cell-penetrating hyperbranched polyprodrug
amphiphiles for synergistic reductive milieu-triggered drug release and
enhanced magnetic resonance signals. J Am Chem Soc. 2015; 137: 362-8.
16. Yan
LS,
Yang
LX,
He
HY,
et
al.
Photo-cross-linked
mPEG-poly(gamma-cinnamyl-L-glutamate) micelles as stable drug carriers.
Polym Chem. 2012; 3: 1300-7.
17. Yan LS, Wu WB, Zhao W, et al. Reduction-sensitive core-cross-linked
mPEG–poly(ester-carbonate) micelles for glutathione-triggered intracellular
drug release. Polym Chem. 2012; 3: 2403-12.
18. Hao TN, Chen DW, Liu KX, et al. Micelles of d-alpha-tocopheryl polyethylene
glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of
multidrug resistance. ACS Appl Mater Interfaces. 2015; 7: 18064-75.
19. Jiang CJ, Wang HX, Zhang XM, et al. Deoxycholic acid-modified
chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for
enhanced antitumor efficacy. Int J Pharm. 2014; 475: 60-8.
20. Wang JG, Wang HX, Li J, et al. iRGD-decorated polymeric nanoparticles for
the efficient delivery of vandetanib to hepatocellular carcinoma: preparation
and in vitro and in vivo evaluation. ACS Appl Mater Interfaces. 2016; 8:
19228-37.
c-caspase
3,
cleaved
caspase
3;
CDK1,
FACS,
cyclin-dependent
fluorescence-activated cell sorting; SD, Sprague
Dawley.
kinase
1;
Acknowledgements
This work was supported by the National
Natural Science Foundation of China (Nos. 81571799,
81572361, 81372621, 81773193 and 21202147), the
Zhejiang Province Preeminence Youth Fund (No.
LR16H160001), the Science and Technology Research
Program of Jinhua City (No. 2017-3-020), and the
Project of Public Technology and Application
Research of Zhejiang Province (No. 2017C37139).
21. Miao L, Guo S, Zhang J, et al. Nanoparticles with precise ratiometric
co-loading and co-delivery of gemcitabine monophosphate and cisplatin for
treatment of bladder cancer. Adv Funct Mater. 2014; 24: 6601-11.
22. Matsumoto Y, Nichols JW, Toh K, et al. Vascular bursts enhance permeability
of tumour blood vessels and improve nanoparticle delivery. Nat Nanotechnol.
2016; 11: 533-8.
23. Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor
blood vessels for drug delivery, factors involved, and limitations and
augmentation of the effect. Adv Drug Deliv Rev. 2011; 63: 136-51.
24. Han X, Chen J, Jiang M, et al. Paclitaxel-paclitaxel prodrug nanoassembly as a
versatile nanoplatform for combinational cancer therapy. ACS Appl Mater
Interfaces. 2016; 8: 33506-13.
25. Lin W, Sun T, Xie Z, et al.
A dual-responsive nanocapsule via
disulfide-induced self-assembly for therapeutic agent delivery. Chem Sci.
2016; 7: 1846-52.
Supplementary Material
26. Wang Y, Liu D, Zheng Q, et al. Disulfide bond bridge insertion turns
hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano
Lett. 2014; 14: 5577-83.
27. Wang H, Xie H, Wu J, et al. Structure-based rational design of prodrugs to
enable their combination with polymeric nanoparticle delivery platforms for
enhanced antitumor efficacy. Angew Chem Int Ed Engl. 2014; 53: 11532-7.
28. Dhar S, Kolishetti N, Lippard SJ, et al. Targeted delivery of a cisplatin prodrug
for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci
U S A. 2011; 108: 1850-5.
29. Shi Y, Van dMR, Theek B, et al. Complete regression of xenograft tumors upon
targeted delivery of paclitaxel via pi-pi stacking stabilized polymeric micelles.
ACS Nano. 2015; 9: 3740-52.
30. Alferiev IS, Iyer R, Croucher JL, et al. Nanoparticle-mediated delivery of a
rapidly activatable prodrug of SN-38 for neuroblastoma therapy. Biomaterials.
2015; 51: 22-9.
31. Zhao YM, Fay F, Hak S, et al. Augmenting drug-carrier compatibility
improves tumour nanotherapy efficacy. Nat Commun. 2016; 7:11221-31.
32. Sengupta P, Basu S, Soni S, et al. Cholesterol-tethered platinum II-based
supramolecular nanoparticle increases antitumor efficacy and reduces
nephrotoxicity. Proc Natl Acad Sci U S A. 2012; 109: 11294-9.
33. Wei X, Wang Y, Xiong X, et al. Codelivery of a pi-pi stacked dual anticancer
drug combination with nanocarriers for overcoming multidrug resistance and
tumor metastasis. Adv Funct Mater. 2016; 26: 8266-80.
34. Dhar S, Gu FX, Langer R, et al. Targeted delivery of cisplatin to prostate cancer
cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Proc Natl Acad Sci U S A. 2008; 105: 17356-61.
35. Bala V, Rao SS, Boyd BJ, et al. Prodrug and nanomedicine approaches for the
delivery of the camptothecin analogue SN38. J Control Release. 2013; 172:
48-61.
Supplementary figures and tables.
Competing Interests
The authors have declared that no competing
interest exists.
References
1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.
2011; 144: 646-74.
2. Jia J, Zhu F, Ma X, et al. Mechanisms of drug combinations: interaction and
network perspectives. Nat Rev Drug Discov. 2009; 8: 111-28.
3. Zhang L, Xiao H, Li J, et al. Co-delivery of doxorubicin and arsenite with
reduction and pH dual-sensitive vesicle for synergistic cancer therapy.
Nanoscale. 2016; 8: 12608-17.
4. Sui J, Cui Y, Cai H, et al. Synergistic chemotherapeutic effect of
sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast
carcinoma. Nanoscale. 2017; 9: 2755-67.
5. Wang K, Hu QD, Zhu W, et al. Structure-invertible nanopaticles for triggered
co-delivery of nucleic acids and hydrophobic drugs for combination cancer
therapy. Adv Funct Mater. 2015; 25: 3380-92.
6. Su JG, Sun HP, Meng QS, et al. Enhanced blood suspensibility and
laser-activated tumor-specific drug release of theranostic mesoporous silica
nanoparticles by functionalizing with erythrocyte membranes. Theranostics.
2017; 7: 523-37.